Picture of Keras Resources logo

KRS Keras Resources News Story

0.000.00%
gb flag iconLast trade - 00:00
Basic MaterialsHighly SpeculativeMicro CapValue Trap

REG - Keras Resources PLC - Final Results

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220630:nRSd7257Qa&default-theme=true

RNS Number : 7257Q  Keras Resources PLC  30 June 2022

30 June 2022

Keras Resources plc ('Keras' or the 'Company')

 Final Results

Keras Resources plc (AIM: KRS) announces its final results for the 15 months
ending 31 December 2021.

Highlights

Utah - Diamond Creek Phosphate Mine ("Diamond Creek") - one of the
highest-grade organic phosphate mines in the US, a fully integrated mine to
market asset

·    Spanish Fork milling plant commissioned during June 2021 to increase
installed capacity and enable flexibility to produce a variety of sized
organic rock phosphate products

·    8,520 tonnes of phosphate mined at Diamond Creek during the summer of
2021

·    Total sales of 4,657 tons from June 2020 through to May 2022

·    Increased ownership of Diamond Creek in March 2022 from 51% to 100%
for a total consideration of US$3.2m

·    2022 summer mining season currently underway at Diamond Creek to
produce milled product for the spring 2023 season

·    Construction of a downstream granulator plant is planned for 2022 to
further expand range of phosphate products to attract a price premium in
markets not currently supplied

·    Marketing and sales being strengthened and new offtake agreements
with repeat customers negotiated

·    Focus for 2022 and beyond is developing market share in US organic
fertiliser industry and building Diamond Creek into the premier organic
phosphate producer in the US

 

Corporate

 

·    £550,000 and £1,000,000 fundraising completed December 2020 and
January 2021

·    Further £1,950,000 (before costs) raised at a premium and supported
by a new cornerstone investor, First Uranium Resources Ltd, a Canadian public
company active in the North American phosphate market, to facilitate growing a
portfolio of North American phosphate projects

·    Board Changes

o  Graham Stacey appointed to the Board in November 2021 and assumed
responsibility for the Diamond Creek mine in March 2022 - assumed the role as
CEO on 1 June 2022

o  Russell Lamming has stepped down as CEO and assumed the role as
Non-Executive Director as of 1 June 2022, and will become Non-Executive
Chairman as of 1 September 2022

o  Brian Moritz stepping down as Non-Executive Chairman as of 1 September
2022, will assume the role as Non-Executive Director and remain as Company
Secretary

 

Graham Stacey, Keras Resources Chief Executive Officer, commented, "2021 was
not without its challenges, however, we were very pleased to have announced
the acquisition of full ownership and to have assumed full operational and
marketing control of Diamond Creek in March 2022. The completion of a £1.95m
capital raise which saw First Uranium Resources Ltd come in as a cornerstone
investor, and the acquisition of an additional 7% in the market by First
Uranium associate AxCap Ventures was particularly encouraging.

 

"We will now focus on delivering on the current summer mining season at
Diamond Creek to September 2022, continue to negotiate new offtake agreements
with repeat customers and more importantly identify new outlets for our
existing product mix. Near-term growth plans also include installing a
downstream granulator plant which will allow us to further broaden our current
product offering, attracting premium prices in the markets that those products
bring.

 

"We believe the Company is excellently positioned to deliver into the growing
organic agricultural sector underpinned by the macro-economic tailwinds of the
global fertiliser markets. Ultimately our mission is to penetrate and increase
our market share in the US organic fertiliser industry and to build Diamond
Creek into the premier organic phosphate producer in the US.

 

"I look forward to working closely with our new cornerstone investor(s) to
lever off synergies that their investment will bring and continuing to build
production and sales at Diamond Creek, as we move forward in this exciting
chapter in the Company's evolution and growth."

 

Posting of Annual Report and Notice of AGM and General Meeting

 

Copies of the Company's full Annual Report and Financial Statements (the
"Annual Report") will be made available to download from the
Company's website shortly
at https://www.kerasplc.com/constitutional-documents/
(https://www.kerasplc.com/constitutional-documents/) and will also be posted
to shareholders today along with the notice of its Annual General Meeting
("AGM") and General Meeting which are to be held at 11am and 11.15am
respectively on the 25(th) July 2022.

 

Chairman's Statement

 

I am pleased to provide an update on our progress since my last report and set
out our outlook for the business going forward.

 

The main activity of Keras is now in developing the Diamond Creek organic
phosphate mine in Utah, USA, and we announced on 30 March 2022 that Keras had
increased its ownership from 51% to 100%. Subsequently, Keras concluded a
£1.95m (before costs) fund raising, underpinned by a new cornerstone investor
who is focussed on growing a portfolio of North American phosphate projects.

 

The Diamond Creek phosphate mine

 

Despite facing challenges throughout the reporting period, we continued to
make significant progress with our fully integrated mine to market operation
at Diamond Creek in Utah which is believed to be one of the highest grade
organic rock phosphate deposits in the US.

 

The Diamond Creek phosphate mine, which is situated on an 840 acre Federal
Lease, and the Spanish Fork Processing Facility, are owned and operated by
Falcon Isle Resources LLC and Falcon Isle Holdings LLC (collectively 'Falcon
Isle'). Keras initially acquired a 51% equity interest in Falcon Isle in July
2020 for nominal consideration by agreeing to loan a total of $2.5m to Falcon
Isle in tranches. The last tranche of the loan was advanced at the end of
December 2020, so that Falcon Isle has been accounted for as a subsidiary of
Keras for 2021. Post-period end, in March 2022, we were pleased to announce
that Keras had agreed to acquire our partner's 49% equity interest in Falcon
Isle, increasing our holding from 51% to 100%, for a total consideration of
US$3.2m, which includes loans repaid to the vendor totalling US $1,816,527.
This agreement made Falcon Isle a wholly owned subsidiary of Keras, allowing
Graham Stacey, previously COO of Keras, to take over full management control
of the operation, and become CEO of the Group. Importantly, the agreement
avoided a lengthy and costly litigation process, operations recommenced
immediately, and we continue to meet customers' demand for our phosphate
product.

 

Located approximately 80km south-east of Salt Lake City, Diamond Creek is one
of the highest-grade organic phosphate deposits in the US, and our mission
going forward is to build the operation into the premier organic phosphate
producer in the US. Our focus and market segment is in supporting sustainable
agriculture and we are strong advocates for the benefits of enhancing soil
health. Our organic phosphate fertiliser products can help farmers realise
better crop growth and yields while reducing the soil degradation seen when
farmers use chemically manufactured fertilisers.

 

The mine is fully permitted, and the Spanish Fork processing plant is close to
infrastructure and ideally located to take advantage of Salt Lake City's
resources including labour, supplies, industrial engineering and financial
services. The integrated mining and processing operation has compelling
economics with a low capex, simple low-intensity seasonal mining operation and
our in-house processing plant has flexibility to beneficiate a variety of
organic rock phosphate products throughout the period.  The mined material
only requires crushing, milling and bagging before being sold as high-grade
organic rock phosphate fertiliser - a 23% total phosphorus pentoxide
('P(2)0(5)') premium product and importantly with minimum 12% available
P(2)0(5) which is significantly higher than our competitors.

 

The project has a pre-stripped area with production drilling information
delineating approximately 2 years of planned production still in-situ.
However, we believe there is significant scope to increase the current life of
mine at Diamond Creek with historic "surface mineable resources" representing
in excess of 60 years of production. Part of the funds raised recently will be
used to establish a NI 43-101 compliant mineral resource at Diamond Creek.

 

Immediately post Keras' injection of funding into Falcon Isle, beneficiation
was undertaken on a toll basis with a key contractor. The Company subsequently
took the decision to move processing in-house and construct a new plant at
Spanish Fork, 30km from Diamond Creek. This was to both increase the installed
capacity and enable flexibility to beneficiate a variety or organic phosphate
products to offer across our marketing campaign. The plant was fabricated and
shipped from Shanghai, with construction commencing on site in Spanish Fork in
February 2021 and commissioning was successfully completed at the end of June,
2021.

 

In November 2021 the Company announced it was in dispute with its 49% partner
in Falcon Isle due to a capital shortfall resulting in all operations at
Diamond Creek being temporarily halted and Keras engaging local US legal
representatives to enforce its rights under the terms of the initial
transaction.  The 2021 mining season had already been completed prior to
operations being suspended and sales continued to be made from processed
material in stock over the winter period.

 

In 2021, 8,520 tons of phosphate were mined and delivered to the laydown area
at Diamond Creek.  Sales totalled 4,657 tons of phosphate from June 2020
through to May 2022.  Since Keras took control of the marketing function and
with both the mining and processing facilities now operating as planned
developing market share will be our primary focus for the next two years.
Production rhythm is key to the supply of both consistent quantity and quality
products which Keras' operational control and our recent fund-raise has now
enabled.

 

A key component of our marketing effort will be growth tests across a range of
crops and soil types. This process is planned to run for the balance of 2022
and will provide focussed market feedback to support of our product use across
crop types, regions and planting seasons.

 

We are now looking forward to commencing our mining season at Diamond Creek
which takes place during the summer season from July to September, while the
mine site is free of snow.

 

Nayéga manganese mine / Togo

 

On the 18 October 2019 the Council of Ministers of the Republic of Togo
published a decree granting the right for large-scale exploitation of the
manganese deposit at Nayéga to the Company's subsidiary, Société Générale
des Mines ("SGM").  Since that date the Company has concentrated its efforts
on obtaining the required Exploitation Permit. The terms of the permit and
associated protocols have been agreed, and SGM has been converted from a
private to a public company, as required by law and in compliance with the
draft Mining Convention. However, the exploitation permit approval has not
been forthcoming.

 

Financial review

The Consolidated Statement of Comprehensive Income for the 15-month period
shows a loss of £1,948,000 (2020 - loss £1,257,000). The results of the two
periods are not strictly comparable due to the different lengths of the
periods reported on as a result of the change in year-end to 31 December.
The loss for the period under review has suffered from delays in realising the
value of the Diamond Creek mine which are referred to above.

 

Also included is a technical loss amounting to £398,000 due to the IFRS
requirement to treat the previous minority interest in Falcon Isle as having
been disposed of and the 51% majority acquired as a separate transaction.

 

During the period Keras undertook two fund raisings, in December 2020 and
January 2021, raising £550,000 and £1,000,000 respectively (before costs),
primarily to facilitate finance for the Diamond Creek mine, and also for
working capital generally.

 

In May 2022 Keras raised a further £1,950,000 (before costs) at a premium to
the previous share price, of which £960,000 was subscribed by a new
cornerstone investor, First Uranium Resources Ltd, a Canadian public company
active in the North American phosphate market. These funds will be used for
the first tranche of US$800,000 of the cost of acquiring the former minority
interest in Falcon Isle, the establishment of a NI 43-101 compliant Mineral
Resource at Diamond Creek, expansion of the Falcon Isle business into other
fields of activity and general working capital.

 

First Uranium initially acquired a 10.03% interest in the Company by
participating in the above Capital raise and, subsequent to this, AxCap
Ventures, an associated company of First Uranium, accumulated a further 7.04%
interest in Keras through on-market trades.  First Uranium's support for the
Company is part of their focus on developing a portfolio of assets in the
North American phosphate market as it sees this as a key growth commodity
within the resource sector.

 

   Directors and Management

 

Graham Stacey, who has been COO since 2020, was appointed to the Board in
November 2021 and assumed responsibility for the Diamond Creek mine in March
2022. He is in the process of relocating from Johannesburg to Utah. On 1 June
2022 Graham took over the role of Chief Executive Officer from Russell
Lamming, who has become a Non-Executive Director. I would like to welcome
Graham to the Board and thank Russell for his untiring work during his tenure
as CEO.

 

Later in the year, on 1 September 2022, Russell will take over from me as
Non-Executive Chairman. I will remain a Non-Executive Director and Company
Secretary, and I will continue to provide oversight of the Company's finances.

 

Outlook

 

With the closing of the £1.95m capital raise and securing 100% of our
high-grade organic phosphate Diamond Creek mine, we believe the Company is
excellently positioned to deliver into the growing organic agricultural
sector. This sector is underpinned by the macro-economic tailwinds of the
global fertiliser markets, and we remain bullish on our premium phosphate
product and our position as we continue to build market share.

 

Plans for expansion to broaden our product mix are under way and we continue
to negotiate new offtake agreements with our repeat customers. The
construction of a downstream granulator plant is planned for 2022 to allow us
to further expand the range of our products from five sized dry products to
include two sized granulated products which will attract a price premium in
markets that we are not currently supplying. Now that we are fully in charge
of operations the Directors are confident that Falcon Isle will be a
profitable and valuable asset for the Group, and we look forward to updating
our shareholders on our progress as we continue to ramp up the production
profile and build our position and market share of the fast-growing US organic
phosphate market.

 

Finally, I would like to take this opportunity to thank my colleagues on the
Board and our management team for their hard work, and shareholders for their
continuing support.

 

 

Brian Moritz

Chairman

29 June 2022

 

 

Strategic Report

 

Having acquired 100% control of the Diamond Creek asset, the Group's strategy
is to progressively enhance shareholder value through building market share
for its products within the North American organic fertiliser market. At the
same time ongoing value engineering initiatives will continue to streamline
operations and rationalise costs to ensure consistent product quality and
volumes, all aimed at increasing margins.  In the longer-term, enhancing
value of that asset will involve both organic expansion as well as identifying
value-accretive projects/businesses with natural synergies to increase scale
and to add value to the Company.

 

Diamond Creek is one of the highest-grade organic phosphate mines in the US,
and the Company's purpose is to build the operation into the premier organic
phosphate producer in the US. Keras supports sustainable, regenerative
agriculture and is an advocate for the benefits of enhancing soil health.
Diamond Creek's organic phosphate fertiliser products can help farmers realise
better crop growth and yields, reduce soil degradation, build and maintain
soil organic matter to improve overall soil health, and ultimately reduce
CO(2) levels in the atmosphere through carbon sequestration.

 

Organic fertilisers' significantly lower carbon footprint relative to
traditional synthetic/chemical fertilisers and will continue to support demand
and pricing for organic replacements including rock phosphate. Keras is
therefore also looking at developing opportunities around carbon sequestration
and the associated carbon credits to further augment its business and enhance
shareholder value. Diamond Creek's organic phosphate products have the
potential to tap directly into this rapidly growing market and the Company is
looking at developing and enhancing the value of this aspect of its portfolio
and in-turn generate greater returns for shareholders.

 

The Group's business model has established the Company as an efficient,
high-quality and low-cost producer direct into the North American fertiliser
market.

 

During the reporting period the Group was focussed largely on developing
operations at Diamond Creek to maximise operational efficiencies, build market
share and generate cashflow. The mine is owned by Falcon Isle, in which the
Company held a 51% equity interest during the reporting period, subsequently
increasing this to 100% in March 2022.

 

The Company is aware of a national geophysical survey being undertaken by the
Togolese Ministry of Mines and Energy and we do not expect the permitting
process at our Nayéga manganese project to be concluded prior to the survey
being completed.

 

In exploring and developing mines to exploit mineral deposits, the Group
accepts that not all its exploration will be successful but also that the
rewards for success can be high. It therefore expects that its shareholders
will be invested for potential capital growth, taking a long-term view of
management's good track record in mineral discovery and development. The
Directors have continued to invest in the Company and currently hold
approximately 21.3% of the issued shares in Keras, after allowing for the
substantial fund raisings since the period end. We believe this stake provides
further evidence of the Board's belief in and commitment to its strategy.

 

To date, the Group has financed its activities through equity raisings. As the
Group's projects become more advanced, the Board will seek mining and/or
offtake finance and may also investigate strategic opportunities to obtain
funding for projects from future customers via pre-payments, royalties, and
other marketing arrangements.

 

Financial and Performance Review

Turnover in the period under review comprised sales of phosphate fertilisers
by Falcon Isle. Turnover of £452,000 was constrained by construction of the
processing plant, which was only operational for the final six months of the
period, as well as the problems with working capital referred to previously.

 

The results of the Group are set out in detail in the financial statements.
The Group reports a loss for the period of £1,948,000 (2020: loss
£1,257,000).

 

Fixed assets total £5,375,000 (2020: £1,332,000), which includes the bulk
sample plant and associated infrastructure at the Nayéga project, and the
Falcon Isle processing plant totalling £544,000 (2020: £262,000).

 

The Directors have assessed the carrying values of Falcon Isle and SGM and no
impairment has been deemed necessary.

 

Key Performance Indicators (KPIs)

 

During the period the Board monitored the following KPIs:

·    Cash flow and working capital:

o  Short (<3 months) and long-term cashflow models are prepared to monitor
and forecast the Group's funding needs;

o  Management accounts prepared on a monthly basis for the Group's key
subsidiaries and quarterly on a consolidated basis.

 

Mining projects

 

North America

Keras acquired an interest in Falcon Isle, holder of the Diamond Creek
phosphate mine, in July 2020, and increased its interest to 51% in December
2020. Keras acquired the outstanding 49% post the reporting period in March
2022. The mine is situated approximately 80km SSE of Salt Lake City, Utah.
Diamond Creek is a fully permitted, high-grade direct shipping ore ("DSO"),
low capex organic phosphate mine, which has significant historical estimated
in-situ tonnage (mineral resources have not been classified according to
modern International Reporting Standards) with sufficient phosphate ore
exposed in-situ to provide for the 2022 and 2023 mining seasons before any
overburden stripping is required.  The phosphate mineralisation is
concentrated in the shale beds of the Meade Peak Member of the Phosphoria
Formation.  The mineralised zone is c.3m thick at the base of the Meade Peake
Member and averages 23% total P(2)O(5) with guaranteed available P(2)O(5) of
12%.  Historic reports vary with "surface mineable resources" ranging from
3.10Mt to 4.60Mt.  At an internally estimated peak production rate of
23.5ktpa, the opencast resources alone represent a significant mine life.

 

The 2021 mining campaign was completed in October 2021 with a total of 8,520
ore tons extracted from the mine. Beneficiation during the reporting period
was undertaken through a combination of contractor toll-milling (producing
10mesh and -50mesh products) and Falcon Isle owned milling infrastructure. A
new high-pressure rolls milling plant was successfully commissioned during
June 2021 which has the capacity to produce steady-state product of 23,500
tons per month. The plant comprises front-end feed, primary crush, milling,
dust extraction, 50lb and 1ton bagging circuits to produce a range of products
including -50 mesh, -100 mesh and -350 mesh powders in either 50lb bags or
1ton bags (totes). A granulation plant was procured and delivered to our
Spanish Fork site during September 2021 with construction and commissioning
planned for the second half of 2022 which will further broaden our product
range to include high margin granulated organic phosphate.

 

The product has received Organic Certification by all three key certification
agencies in the USA - California (CDFA), Washington State (WSDA) and the
federal Organic Materials Review Institute (OMRI).  As a Direct Shipping Ore
(DSO) it requires no chemical/synthetic upgrade processes. Our rock contains
low heavy metal impurities, significantly higher available P(2)O(5) than any
other organic rock phosphate in North America, and a calcium content of
>25%.

 

Africa

 

Keras currently holds an 85% interest in the Nayéga manganese project in
Togo, which covers 19,903 hectares in northern Togo, held through Société
Générale des Mines SA (SGM). As set out in the Chairman's Statement, SGM is
still waiting for the issue of the exploitation permit.

 

Sustainability

 

Keras is committed to responsible mining and upholding ESG best practice
across our business. We care about all our stakeholders and are focused on
looking to create value and benefits for all whilst seeking to manage and
mitigate the potential impacts that our operations may have. We are focussed
on mining an essential resource that can contribute to a more sustainable
future and importantly sustainable and regenerative agriculture. With the
Diamond Creek mine we are running a simple operation with only crushing &
milling requirements and will look to maintain our low carbon footprint. We
are focused on meeting our commitments across the ESG space and will continue
to be proactive in this area as we look to develop and sustain a positive
legacy.

 

Risk Management

 

The Board regularly reviews the risks to which the Group is exposed and
ensures through its meetings and regular reporting that these risks are
minimised as far as possible.

 

The principal risks and uncertainties facing the Group at this stage in its
development are:

 

Market Risk

 

Unlike marketing globally traded, indexed commodities into international
markets, growing market share within the niche organic fertiliser market
within North America presents risk in terms of pricing and volume.

 

The Group has employed a head of marketing to develop and implement a
marketing strategy which will be a key focus area to build market share.  The
business has a range of existing customers, three of which are anchor clients
having provided commitments to purchase a pleasing base load of our planned
annual production. Our marketing strategy rollout will include presence at
industry trade exhibitions and conferences, as well as regular regional direct
contact visits with a comprehensive schedule of contacts within the wholesale
and distribution segments of the organic fertiliser market. Our business model
will largely be driven by uptake from co-operative type clients with wide
distribution networks, rather than selling directly to farmers themselves.

 

Exploration Risk

 

The Group's business has been primarily mineral exploration and evaluation
which are speculative activities and whilst the Directors are satisfied that
good progress is being made, there is no certainty that the Group will be
successful in the definition of economic mineral deposits, or that it will
proceed to the development of any of its projects or otherwise realise their
value.

 

The Group aims to mitigate this risk when evaluating new business
opportunities by targeting areas of potential where there is at least some
historical drilling or geological data available.

 

Resource Risk

 

All mineral projects have risk associated with defined grade and continuity.
Mineral reserves and resources are calculated by the Group in accordance with
accepted industry standards and codes but are always subject to uncertainties
in the underlying assumptions which include geological projection and
commodity price assumptions.

 

The Group reports mineral resources and ore reserves in accordance with
internationally approved codes where our operations/projects are located,
which set minimum standards for public reporting of mineral exploration
results, mineral resources and ore reserves.

 

Development Risk

 

Delays in permitting, financing and commissioning a project may result in
delays to the Group meeting development and/or production targets. Changes in
commodity prices can affect the economic viability of mining projects and
affect decisions on continuing exploration activity.

 

Mining and Processing Technical Risk

 

Notwithstanding the completion of metallurgical testwork, trial mining and
pilot studies indicating the technical viability of a mining operation,
variations in mineralogy, mineral continuity, ground stability, ground water
conditions and other geological conditions may still render a mining and
processing operation economically or technically non-viable.

 

The Group has a small team of mining professionals experienced in geological
evaluation, exploration, financing and development of mining projects. To
mitigate development risk, the Group supplements this from time to time with
engagement of external expert consultants and contractors.

 

Environmental Risk

 

Exploration and development of a project can be adversely affected by
environmental legislation and the unforeseen results of environmental studies
carried out during evaluation of a project. Once a project is in production
unforeseen events can give rise to environmental liabilities.

 

As Keras undertakes mining operations, any disturbance to the environment
during this phase is required to be rehabilitated in accordance with the
prevailing regulations of the countries in which we operate as well as to
international best-practice.

 

Given the Group's size and scale it is not considered practical or cost
effective to collect and report data on carbon emissions.

 

Financing & Liquidity Risk

 

The Group has had an ongoing requirement to fund its activities through the
equity markets and may in future need obtain finance for further project
development. There is no certainty such funds will be available when needed.
To date, Keras has managed to raise funds primarily through equity placements
despite the very difficult markets that currently exist for raising funding in
the junior mining industry.

 

Political Risk

 

All countries carry political risk that can lead to interruption of activity.
Politically stable countries can have enhanced environmental and social
permitting risks, risks of strikes and changes to taxation whereas less
developed countries can have, in addition, risks associated with changes to
the legal framework, civil unrest and government expropriation of assets.

 

Partner Risk

 

Whilst there has been no past evidence of this, the Group can be adversely
affected if joint venture or equity partners are unable or unwilling to
perform their obligations or fund their share of future developments. Keras no
longer operates with either equity or joint venture partners having secured
100% of the Diamond Creek project.

 

Bribery Risk

The Group has adopted an anti-corruption and bribery policy and whistle
blowing policy under the Bribery Act 2010. Notwithstanding this, the Group may
be held liable for offences under that Act committed by its employees or
subcontractors, whether or not the Group or the Directors had knowledge of the
commission of such offences.

 

Financial Instruments

 

Details of risks associated with the Group's financial instruments are given
in Note 26 to the financial statements. Keras does not utilise any complex or
derivative financial instruments.

 

COVID-19

 

Travel and shipping restrictions in place globally during 2021 had a direct
impact on timing and cost of delivery of plant and equipment to the USA.
However, given recent developments the Directors do not believe that Covid 19
will have a material effect on the Company or its operations going forward.

 

Insurance Coverage

 

The Group maintains a suite of insurance coverage that is appropriate for the
Group and Company. This is arranged via a specialist mining insurance broker
and coverage includes public and products liability, travel, property and
medical coverage and assistance while Group employees and consultants are
travelling on Group business. This is reviewed at least annually and adapted
as the Group's scale and nature of activities changes. Keras also has
Directors and Officers insurance in place.

 

Internal Controls and Risk Management

 

The Directors are responsible for the Group's system of internal financial
control. Although no system of internal financial control can provide absolute
assurance against material misstatement or loss, the Group's system is
designed to provide reasonable assurance that problems are identified on a
timely basis and dealt with appropriately.

In carrying out their responsibilities, the Directors have put in place a
framework of controls to ensure as far as possible that ongoing financial
performance is monitored in a timely manner, that corrective action is taken
and that risk is identified as early as practically possible. The Directors
review the effectiveness of internal financial control at least annually.

 

The Board, subject to delegated authority, reviews capital investment,
property sales and purchases, additional borrowing facilities, guarantees and
insurance arrangements.

 

The Board takes account of the significance of social, environmental and
ethical matters affecting the business of the Group. At this stage in the
Group's development the Board has not adopted a specific policy on Corporate
Social Responsibility as it has a limited pool of stakeholders other than its
shareholders. Rather, the Board seeks to protect the interests of Keras'
stakeholders through individual policies and through ethical and transparent
actions.

 

The Group has adopted an anti-corruption and bribery policy and a whistle
blowing policy as stated previously.

 

Shareholders

 

The Directors are always prepared, where practicable and subject to
confidentiality under the AIM Rules, to enter into dialogue with shareholders
to promote a mutual understanding of objectives. The Annual General Meeting
provides the Board with an opportunity to informally meet and communicate
directly with investors.

 

Employees

 

The Group operates primarily through contractors. Notwithstanding this, the
Group engages its employees to understand all aspects of the Group's business
and seeks to remunerate its employees fairly, being flexible where
practicable. The Group gives full and fair consideration to applications for
employment received regardless of age, gender, colour, ethnicity, disability,
nationality, religious beliefs, transgender status or sexual orientation. The
Group takes account of employees' interests when making decisions and welcomes
suggestions from employees aimed at improving the Group's performance.

 

The Group currently operates in the USA and Togo. It recruits locally as many
of its employees and contractors as practicable.

 

The Company has four directors, all are male.

 

Suppliers and Contractors

 

The Group recognises that the goodwill of its contractors, consultants and
suppliers is important to its business success and seeks to build and maintain
this goodwill through fair dealings. The Group has a prompt payment policy and
seeks to settle all agreed liabilities within the terms agreed with suppliers.
Contractors are appointed based on a detailed assessment of their
capabilities, capacity and track record.

 

Health and Safety

 

The Board recognises that it has a responsibility to provide strategic
leadership and direction in the development of the Group's health and safety
strategy in order to protect all of its stakeholders. The Group does not have
a formal health and safety policy at this time. This is re-evaluated as and
when the Group's nature and scale of activities expand.

 

Section 172 statement

The Directors believe they have acted in the way most likely to promote the
success of the Company for the benefit of its members as a whole, as required
by s172 of the Companies Act 2006.

 

The requirements of s172 are for the Directors to:

·    Consider the likely consequences of any decision in the long-term;

·    Act fairly between the members of the Company;

·    Maintain a reputation for high standards of business conduct;

·    Consider the interests of the Company's employees;

·    Foster the Company's relationships with suppliers, customers and
others; and

·    Consider the impact of the Company's operations on the community and
the environment.

 

The Company's operations and strategic aims are set out throughout the
Strategic Report and in the Chairman's Statement, and relationships with
stakeholders are also dealt with in the Corporate Governance Statement.

 

 

Graham Stacey

Director

This Strategic Report was approved by the Board of Directors on 29 June 2022

 

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

FOR THE 15 MONTHS ENDED 31 DECEMBER 2021

 

 

                                                                                                                             15 months ended 31 December      Year ended 30 September 2020

                                                                                                                             2021                             £'000

                                                                                                                Notes        £'000
 Continuing operations
 Revenue                                                                                                                     452                              -
 Cost of sales                                                                                                               (496)                            -
 Gross profit                                                                                                                (44)                             -
 Administrative and exploration expenses                                                                                     (1,448)                          (1,235)
 Loss from operating activities                                                                                              (1492)                           (1,235)

 Finance costs                                                                                                  11           (43)                             (3)
 Net finance costs                                                                                                           (43)                             (3)

 Share of net loss of associates accounted for using the equity method                                                       (116)                            (4)

 Loss on change of ownership

                                                                                                                15           (363)                            -

 Loss before taxation                                                                                                        (2,014)                          (1,242)

 Tax                                                                                                            12           -                                -
 Loss for the period/year                                                                                                    (2,014)                          (1,242)

 Other comprehensive income - items that may be subsequently reclassified to
 profit or loss
 Exchange translation on foreign operations                                                                                  66                               (15)

 Total comprehensive loss for the period/year                                                                                (1,948)                          (1,257)

 

 Loss attributable to:
 Owners of the Company                                                             (1,729)    (1,181)
 Non-controlling interests                                                         (285)      (61)
 Loss for the period/year                                                          (2,014)    (1,242)

 Total comprehensive loss attributable to:
 Owners of the Company                                                             (1,670)    (1,194)
 Non-controlling interests                                                         (278)      (63)
 Total comprehensive loss for the period/year                                      (1,948)    (1,257)

 Earnings per share
 Basic and diluted loss per share (pence)                                  22      (0.033)    (0.040)

 

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

AS AT 31 DECEMBER 2021

 

                                                                                                         31 December 2021      30 September 2020

                                                                                                         £'000                 £'000

                                                                                             Notes
 Assets
 Property, plant and equipment                                                               13          554                   263
 Intangible assets                                                                           14          4,606                 1,069
 Right of use asset                                                                          16          215                   -
 Investments accounted for using the equity method                                           15          -                     1,622
 Non-current assets                                                                                      5,375                 2,954

 Inventory                                                                                   18          273
 Other investments                                                                           16          -                     -
 Trade and other receivables                                                                 19          94                    83
 Cash and cash equivalents                                                                   20          166                   438
 Current assets                                                                                          533                   521
 Total assets                                                                                            5,908                 3,475

 Equity
 Share capital                                                                               21          630                   487
 Share premium                                                                                           4,033                 2,637
 Other reserves                                                                                          111                   16
 Retained (deficit)/earnings                                                                             (1,721)               8
 Equity attributable to owners of the Company                                                            3,053                 3,148
 Non-controlling interests                                                                               229                   (140)
 Total equity                                                                                            3,282                 3,008

 Liabilities
 Trade and other payables                                                                    24          1,658                 467

 Lease liabilities - current                                                                 16          107                   -
 Current liabilities                                                                                     1,765                 467
 Trade and other payables                                                                    24          749                   -
 Lease liabilities - non-current                                                             16          112                   -
 Non-current liabilities                                                                                 861                   -
 Total liabilities                                                                                       2,626                 467
 Total equity and liabilities                                                                            5,908                 3,475

 

 

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

FOR THE 15 MONTHS ENDED 31 DECEMBER 2021

 

 Attributable to owners of the Company
                                                                Share     Share premium     Share                 Exchange reserve           Financial        Retained earnings/(deficit)  Total            Non-controlling interests                Total equity

                                                                capital                     option                                           assets at

                                                                                            /warrant reserve                                 FVOCI            £'000                                         £'000

                                                                          £'000             £'000                 £'000                                                                                                                              £'000

                                                                £'000                                                                        £'000                                         £'000
 Balance at 1 October 2020                                      487                2,637               63                    (47)            -                8                                 3,148                  (140)                         3,008

 Loss for the period                                            -                  -                   -                     -               -                (1,729)                           (1,729)                (285)                         (2,014)
 Other comprehensive income                                     -                  -                   -                     58              -                -                                 58                     8                             66
 Total comprehensive loss for the period                        -                  -                   -                     58              -                (1,729)                           (1,671)                (277)                         (1,948)

 Issue of ordinary shares                                       143                1,469               -                     -               -                -                                 1,612                  -                             1,612
 Costs of share issue                                           -                  (73)                -                     -               -                -                                 (73)                   -                             (73)
 Share-based payment transactions                               -                  -                   37                    -               -                -                                 37                     -                             37
 Non-controlling interest on acquisition of subsidiary          -                  -                   -                     -               -                -                                 -                      646                           646

 Transactions with owners, recognised directly in equity        143                1,396               37                    -               -                -                                 1,576                  646                           2,222

 Balance at 31 December 2021                                    630                4,033               100                   11              -                (1,721)                           3,053                  229                           3,382

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

FOR THE YEAR ENDED 30 SEPTEMBER 2020

 

 

                               Attributable to owners of the Company
                                                                                     Share     Share premium      Share         Exchange reserve           Financial assets at FVOCI       Retained (deficit)/earnings  Total          Non-controlling interests         Total equity

                                                                                     capital                      option                                   £'000                                                                       £'000

                                                                                               £'000              reserve       £'000                                                      £'000                                                                         £'000

                                                                                     £'000                        £'000                                                                                                 £'000
 Balance at 1 October 2019                                                           7,266              10,938           -                 (33)            3,459                           (10,310)                           11,320                  (76)               11,244

 Loss for the year                                                                   -                  -                -                 -               -                               (1,181)                            (1,181)                 (61)               (1,242)
 Other comprehensive income                                                          -                  -                -                 (16)            -                               4                                  (12)                    (3)                (15)
 Total comprehensive loss for the year                                               -                  -                -                 (16)            -                               (1,177)                            (1,193)                 (64)               (1,257)

 Capital reduction                                                                   (7,023)            (10,938)         -                 -               -                               17,961                             -                       -                  -
 Demerger and recycling of OCI reserve                                               -                  -                -                 -               (3,459)                         (6,464)                            (9,923)                 -                  (9,923)
 Issue of ordinary shares                                                            244                2,718            -                 -               -                               -                                  2,962                   -                  2,962
 Costs of share issue                                                                -                  (81)             -                 -               -                               -                                  (81)                    -                  (81)
 Share-based payment transactions                                                    -                  -                63                -               -                               -                                  63                      -                  63
 Transfer                                                                            -                  -                -                 2               -                               (2)                                -                       -                  -
 Total transactions with owners, recognised directly in equity                       (6,779)            (8,301)          63                2               (3,459)                         11,495                             (6,979)                 -                  (6,979)

 Balance at 30 September 2020                                                        487                2,637            63                (47)            -                               8                                  3,148                   (140)              3,008

 

 

 

CONSOLIDATED STATEMENT OF CASH FLOWS

FOR THE 15 MONTHS ENDED 31 DECEMBER 2021

 

 

                                                                                                                15 months ended 31 December 2021      Year ended 30 September 2020

                                                                                                                £'000                                 £'000
 Cash flows from operating activities
 Loss from operating activities                                                                                 (2,014)                               (1,242)
 Adjustments for:
 Depreciation and amortisation                                                                                  172                                   76
 Share of loss of equity accounted associate                                                                    116                                   4
 Compensation on cancellation of SARS scheme                                                                    -                                     120
 Equity-settled share-based payments                                                                            37                                    63
 Foreign exchange differences                                                                                   73                                    (39)
                                                                                                                (1,616)                               (1,018)

 Changes in:
 -  inventory                                                                                                   (216)                                 -
 -  trade and other receivables                                                                                 111                                   2
 -  trade and other payables                                                                                    540                                   278
 Cash generated by/(used in) operating activities                                                               (1,181)                               (738)

 Finance costs                                                                                                  -                                     -
 Taxes paid                                                                                                     -                                     -
 Net cash generated by/(used in) operating activities                                                           (1,181)                               (738)

 Cash flows from investing activities
 Cash acquired on acquisition (note 15)                                                                         158
 Acquisition of property, plant and equipment                                                                   (188)                                 -
 Exploration and licence expenditure                                                                            (538)                                 (1)
 Investment in associate                                                                                        -                                     (938)
 Net cash used in investing activities                                                                          (568)                                 (939)

 Cash flows from financing activities
 Net proceeds from issue of share capital                                                                       1,477                                 1,931
 Net cash flows from financing activities                                                                       1,477                                 1,931

 Net (decrease)/increase in cash and cash equivalents                                                           (272)                                 254

 Cash and cash equivalents at beginning of period/year                                                          438                                   184
 Cash and cash equivalents at 31 December/30 September                                                          166                                   438

 

 

 

The following significant non-cash transactions took place in the period ended
31 December 2021:

·    Shares were issued to settle a total of £55,000 due to creditors.

·    The investment in Falcon Isle became a subsidiary as detailed in note
15 and the assets and liabilities were acquired.

 

 

COMPANY STATEMENT OF FINANCIAL POSITION

AS AT 31 DECEMBER 2021

 

 

                                                                                             31 December 2021      30 September 2020

                                                                                             £'000                 £'000

                                                                                 Notes
 Assets
 Property, plant and equipment                                                   13          2                     -
 Investments                                                                     15          1,959                 1,622
 Non-current assets                                                                          1,961                 1,622

 Other investments                                                               16          -                     -
 Loans                                                                           17          2,081                 1,534
 Trade and other receivables                                                     19          20                    70
 Cash and cash equivalents                                                       20          122                   428
 Current assets                                                                              2,223                 2,032

 Total assets                                                                                4,184                 3,654

 Equity

 Share capital                                                                   21          630                   487
 Share premium                                                                               4,033                 2,637
 Other reserves                                                                              100                   63
 Retained earnings/(deficit)                                                                 (729)                 285
 Total equity attributable to owners of the Company                                          4,034                 3,472

 Liabilities
 Trade and other payables                                                        24          150                   182
 Current liabilities                                                                         150                   182

 Total liabilities                                                                           150                   182

 Total equity and liabilities                                                                4,184                 3,654

 

 

 

The Company has elected to take the exemption under Section 408 of the
Companies Act 2006 from presenting the Parent Company profit and loss account.
The Parent Company loss for the period was £1,014,000 (year to 30 September
2020: loss of £811,000).

 

The financial statements of Keras Resources PLC, company number 07353748, were
approved by the Board of Directors and authorised for issue on 29 June 2022.
They were signed on its behalf by:

 

Brian Moritz, Director

 

 

COMPANY STATEMENT OF CHANGES IN EQUITY

FOR THE PERIOD ENDED 31 DECEMBER 2021

 

 

                                                             Share               Share premium  Share option              Financial       Retained earnings/ (deficit)      Total

                                                             capital                            /warrant reserve          assets at       £'000                             equity

                                                                                 £'000          £'000                     FVOCI

                                                             £'000                                                        £'000                                             £'000
 Balance at 1 October 2019                                   7,266               10,938         -                         3,459           (10,401)                          11,262

 Loss for the year                                           -                   -              -                         -               (811)                             (811)
 Other comprehensive income                                  -                   -              -                         -               -                                 -

 Total comprehensive loss for the year                              -            -                         -              -               (811)                             (811)

 Capital reduction                                                  (7,023)      (10,938)                  -              -               17,961                            -
 Demerger and recycling of OCI reserve                              -            -                         -              (3,459)         (6,464)                           (9,923)
 Issue of ordinary shares                                           244          2,718                     -              -               -                                 2,962
 Costs of share issue                                               -            (81)                      -              -               -                                 (81)
 Share-based payment transactions                                   -            -                         63             -               -                                 63
 Transactions with owners, recognised directly in equity            (6,779)      (8,301)                   63             (3,459)         11,497                            (6,979)

 Balance at 30 September 2020                                       487          2,637                     63             -               285                               3,472

 

 

 Balance at 1 October 2020                                   487        2,637  63         -     285         3,472

 Loss for the period                                         -          -      -          -     (1,014)     (1,014)
 Other comprehensive income                                  -          -      -          -     -           -

 Total comprehensive loss for the period                         -      -          -      -     (1,014)     (1,014)

 Issue of ordinary shares                                        143    1,469      -      -     -           1,612
 Costs of share issue                                            -      (73)       -      -     -           (73)
 Share-based payment transactions                                -      -          37     -     -           37
 Transactions with owners, recognised directly in equity         143    1,396      37     -     -           1,576

 Balance at 31 December 2021                                     630    4,033      100    -     (729)       4,034

 

 

 

COMPANY STATEMENT OF CASH FLOWS

FOR THE PERIOD ENDED 31 DECEMBER 2021

 

 

                                                                                                                   15 months ended 31 December 2021                   Year ended 30 September 2020

                                                                                                                   £'000                                              £'000
 Cash flows from operating activities
 Loss from operating activities                                                                                    (1,014)                                            (811)
 Adjustments for:
 Depreciation                                                                                                      1                                                  -
 Share of loss of associate                                                                                        116                                                4
 Impairment/write off of loan                                                                                      -                                                  4
 Compensation on cancellation of SARS scheme                                                                       -                                                  120
 Equity-settled share-based payments                                                                               37                                                 63

 Changes in:
 -  trade and other receivables                                                                                                          50                           14
 -  trade and other payables                                                                                       23                                                 25
 Cash generated by/(used in) operating activities                                                                  (787)                                              (581)

 Finance costs                                                                                                     -                                                  -
 Net cash generated by (used in) operating activities                                                              (787)                                              (581)

 Cash flows from investing activities
 Acquisition of property, plant and equipment                                                                      (3)                                                -
 Investment in associate/subsidiary                                                                                (446)                                              (938)
 Net cash used in investing activities                                                                             (449)                                              (938)

 Cash flows from financing activities
 Net proceeds from issue of share capital                                                                          1,477                                              1,931
 Loans (to)/repaid by subsidiaries                                                                                 (547)                                              (159)
 Net cash flows from financing activities                                                                          930                                                1,772

 Net increase/(decrease) in cash and cash equivalents                                                              (306)                                              253

 Cash and cash equivalents at beginning of period/year                                                             428                                                175
 Cash and cash equivalents at 31 December/30 September                                                             122                                                428

 

 

The following significant non-cash transactions took place in the period ended
31 December 2021:

·      Shares were issued to settle a total of £55,000 due to
creditors.

 

 

1.            Reporting entity

Keras Resources PLC is a company domiciled in England and Wales.  The address
of the Company's registered office is Coveham House, Downside Bridge Road,
Cobham KT11 3EP.  The Group currently operates as a miner of and explorer for
mineral resources. The accounting reference date has changed to 31 December to
be coterminous with the main trading subsidiaries.

 

2.            Going concern

The Directors have adopted the going concern basis in preparing the Group and
Company financial statements.  The Group's and Company's business activities
together with the factors likely to affect its future development, performance
and position are set out in the Chairman's Statement and Strategic Report. In
addition, note 25 to the Financial Statements includes the Group's policies
and processes for managing its financial risk management objectives.

 

Since the end of the period, the Company has agreed to acquire the minority
49% interest in Falcon Isle, and to repay loans made by the vendor to Falcon
Isle, for a total consideration of $3.2 million. This amount is payable in
four annual instalments of $800,000 commencing on 1 July 2022.

 

Also since the end of the period, the Company has raised a further £1.95
million, before costs, by the issue of New Ordinary Shares. Part of this will
be used to pay the first instalment of $800,000 to the vendor of Falcon Isle.

 

The Nayéga mine in Togo is in a position to commence operations when the
exploitation licence is granted. Capital expenditure to expand production and
working capital will be primarily provided in the short term by a loan in
association with an offtake agreement which has been agreed in principle.
Should the Company divest its interest in the Nayéga mine, this is expected
to be a cash flow positive transaction.

 

The Directors do not believe that Covid 19 has had a material effect on the
Company or its operations other than travel restrictions which have restricted
the ability of management to visit operations. This has been mitigated by
increased home working and use of electronic communications. Such travel
restrictions have now been removed in most instances.

 

On this basis, the Directors have a reasonable expectation that the Group and
Company have adequate resources to continue in operational existence for the
foreseeable future. As such, the Directors continue to adopt the going concern
basis of accounting.

 

3.            Basis of preparation

 

(a)           Statement of compliance

The consolidated financial statements have been prepared in accordance with
international accounting standards in conformity with the Companies Act
2006("IFRSs"), and the Companies Act 2006 as applicable to entities reporting
in accordance with IFRS.

 

(b)           Basis of measurement

The consolidated financial statements have been prepared on the historical
cost basis unless otherwise stated.

 

(c)           Functional and presentation currency

These consolidated financial statements are presented in Pounds Sterling
('GBP' or '£'), which is the Group's functional currency and is considered by
the Directors to be the most appropriate presentation currency to assist the
users of the financial statements.  All financial information presented in
GBP has been rounded to the nearest thousand, except when otherwise indicated.

 

(d)           Use of estimates and judgements

 

The preparation of the consolidated financial statements in conformity with
IFRS requires management to make judgements, estimates and assumptions that
affect the application of accounting policies and the reported amounts of
assets, liabilities, income and expenses.  The estimates and associated
assumptions are based on historical experience and various other factors that
are believed to be reasonable under the circumstances, the results of which
form the basis of making judgements about carrying values of assets and
liabilities that are not readily apparent from other sources.  Actual results
may differ from these estimates.

 

Estimates and underlying assumptions are reviewed on an ongoing basis.
Revisions to accounting estimates are recognised in the period in which the
estimates are revised if the revision affects only that period, or in the
period of revision and future periods of the revision if it affects both
current and future periods.

 

Critical estimates and assumptions that have the most significant effect on
the amounts recognised in the consolidated financial statements and/or have a
significant risk of resulting in a material adjustment within the next
financial year are as follows:

 

·          Carrying value of intangible
assets
- Notes 4(e)(i) and 14

·          Intercompany receivables (Company
only)                          - Note 19

·          Carrying value of investment in associate
                             - Note 15

·          Fair value of share options and
warrants
                - Note 21

 

4.            Significant accounting policies

The accounting policies set out below have been applied consistently to all
periods presented in these consolidated financial statements, and have been
applied consistently by Group entities.

 

(a)          Basis of consolidation

 

(i)            Business combinations

The Group accounts for business combinations using the acquisition method when
control is transferred to the Group.  The consideration transferred in the
acquisition is generally measured at fair value, as are identifiable net
assets acquired. Any goodwill that arises is tested annually for impairment.
Any gain on a bargain purchase is recognised in profit or loss immediately.
Transaction costs are expensed as incurred, except if related to the issue of
debt or equity securities. The consideration transferred does not include
amounts related to the settlement of pre-existing relationships.  Such
amounts generally are recognised in profit or loss.

 

(ii)           Subsidiaries

Subsidiaries are entities controlled by the Group.  The Group controls an
entity when it is exposed to, or has rights to, variable returns from its
involvement with the entity and has the ability to affect those returns
through its power over the entity.  The financial statements of subsidiaries
are included in the consolidated financial statements from the date that
control commences until the date that control ceases. On disposal of
subsidiaries, any amounts previously recognised in other comprehensive income
in respect of that entity are accounted for as if the Group had directly
disposed of the related assets or liabilities. This might mean that amounts
previously recognised in other comprehensive income are reclassified to profit
or loss.

 

 

(iii)         Associates

Investments in associates are accounted for using the equity method of
accounting after initially being recognised at cost. Loans to associates
denominated in US$ are recognised in sterling in the financial statements at
the period end exchange rate.

 

(iv)          Loss of control

When the Group loses control over a subsidiary, it derecognises the assets and
liabilities of the subsidiary, and any related non-controlling interests and
other components of equity.  Any resulting gain or loss is recognised in
profit or loss.  Any interest retained in the former subsidiary is measured
at fair value when control is lost.

 

(v)           Transactions eliminated on consolidation

Intra-group balances and transactions, and any unrealised income and expenses
arising from intra-group transactions, are eliminated in preparing the
consolidated financial statements.

 

(b)          Foreign currency

Transactions in foreign currencies are translated into the respective
functional currencies of Group entities at exchange rates at the dates of the
transactions. Monetary assets and liabilities denominated in foreign
currencies are translated into the functional currency at the reporting
date.

 

Non-monetary assets and liabilities denominated in foreign currencies that are
measured at fair value in a foreign currency are translated to the functional
currency at the exchange rate when the fair value was determined.
Non-monetary items that are measured based on historical cost in a foreign
currency are translated at the exchange rate at the date of the transaction.

 

(i)            Foreign operations

The assets and liabilities of foreign operations, including goodwill and the
fair value adjustments arising on acquisition, are translated to GBP at
exchange rates at the reporting date.  The income and expenses of foreign
operations are translated to GBP at exchange rates at the dates of the
transactions.

 

Foreign currency differences are recognised in other comprehensive income and
accumulated in the translation reserve except to the extent that the
translation difference is allocated to non-controlling interests.  When a
foreign operation is disposed of in its entirety or partially such that
control, significant influence or joint control is lost, the cumulative amount
in the translation reserve related to that foreign operation is reclassified
to profit or loss as part of the gain or loss on disposal.  If the Group
disposes of part of its interest in a subsidiary but retains control, then the
relevant proportion of the cumulative amount is reattributed to
non-controlling interests.  When the Group disposes of only part of an
associate or joint venture while retaining significant influence or joint
control, the relevant proportion of the cumulative amount is reclassified to
profit or loss.

 

(c)          Financial instruments

 

(i)            Financial assets

The Group's financial assets measured at amortised cost comprise trade and
other receivables, cash and cash equivalents and financial assets at fair
value through other comprehensive income in the consolidated statement of
financial position.

 

Trade receivables and intra group balances are initially recognised at fair
value.  New impairment requirements use an expected credit loss model to
recognise an allowance.  For receivables a simplified approach to measure
expected credit losses during a lifetime expected loss allowance is available
and has been adopted by the Group.  During this process the probability of
non-payment of the receivables is assessed. This probability is then
multiplied by the amount of the expected loss arising from default to
determine the lifetime expected credit loss for the receivables.  For trade
receivables, which are reported net, such provisions are recorded in a
separate provision account with the loss being reported within the
consolidated statement of comprehensive income.  On confirmation that the
trade and intra group receivable will not be collectable, the gross carrying
value of the asset is written off against the provision.

 

Financial assets at fair value through other comprehensive income

These assets are initially measured at fair value. Subsequent to initial
recognition, they are measured at fair value and changes therein, other than
impairment losses and interest income, are recognised in OCI and accumulated
in the fair value reserve.  When these assets are derecognised, any related
balance within the FVOCI reserve is reclassified to retained earnings.

 

(ii)           Non-derivative financial liabilities

The Group initially recognises debt securities issued and subordinated
liabilities on the date that they are originated.  All other financial
liabilities are recognised initially on the trade date, which is the date that
the Group becomes a party to the contractual provisions of the instrument.

 

The Group derecognises a financial liability when its contractual obligations
are discharged, cancelled or expire.

 

The Group classifies non-derivative financial liabilities into the other
financial liabilities category.  Such financial liabilities are recognised
initially at fair value less any directly attributable transaction costs.
Subsequent to initial recognition, these financial liabilities are measured at
amortised cost using the effective interest method.

 

Other financial liabilities comprise trade and other payables.

 

(iii)          Share capital

 

Ordinary shares

Ordinary shares are classified as equity. Incremental costs directly
attributable to the issue of ordinary shares are recognised as a deduction
from equity, net of any tax effects.

 

 

(d)          Property, plant and equipment

 

(i)            Recognition and measurement

Items of property, plant and equipment are measured at cost less accumulated
depreciation and any accumulated impairment losses.  Cost includes
expenditure that is directly attributable to the acquisition of the asset.

 

When parts of an item of property, plant and equipment have different useful
lives, they are accounted for as separate items (major components) of
property, plant and equipment.

 

Any gain or loss on disposal of an item of property, plant and equipment
(calculated as the difference between the net proceeds from disposal and the
carrying amount of the item) is recognised in profit or loss.

 

(ii)           Subsequent expenditure

Subsequent expenditure is capitalised only when it is probable that the future
economic benefits associated with the expenditure will flow to the Group.
Ongoing repairs and maintenance is expensed as incurred.

 

(iii)          Depreciation

Items of property, plant and equipment are depreciated on a straight-line
basis in the statement of comprehensive income over the estimated useful lives
of each component.

 

Items of property, plant and equipment are depreciated from the date that they
are installed and are ready for use, or in respect of internally constructed
assets, from the date that the asset is completed and ready for use.

 

The estimated useful lives of significant items of property, plant and
equipment are as follows:

 

·          plant and
equipment
10 years

·          office
equipment
2 years

·          computer
equipment
2 years

·                          motor
vehicles
5 years

 

Depreciation methods, useful lives and residual values are reviewed at each
reporting date and adjusted if appropriate.

 

(e)          Intangible assets

 

(i)            Prospecting and exploration rights

Rights acquired with subsidiaries are recognised at fair value at the date of
acquisition.  Other rights acquired and evaluation expenditure are recognised
at cost.

 

(ii)           Other intangible assets

Other intangible assets that are acquired by the Group and have finite useful
lives are measured at cost less accumulated amortisation and any accumulated
impairment losses.

 

(iii)          Subsequent expenditure

Subsequent expenditure is capitalised only when it increases the future
economic benefits embodied in the specific asset to which it relates.  All
other expenditure, including expenditure on internally generated goodwill and
brands, is recognised in profit or loss as incurred.

 

(iv)          Amortisation

Intangible assets are amortised in profit or loss over their estimated useful
lives, from the date that they are available for use.

 

The estimated useful lives are as follows:

 

·          Prospecting and exploration rights - Life of mine based
on units of production

 

Amortisation methods, useful lives and residual values are reviewed at each
reporting date and adjusted if appropriate.

 

Amortisation is included within administrative expenses in the statement of
comprehensive income.

 

(f)           Impairment

 

(i)            Non-derivative financial assets

A financial asset not classified as at fair value through profit or loss is
assessed at each reporting date to determine whether there is objective
evidence that it is impaired.  A financial asset is impaired if there is
objective evidence of impairment as a result of one or more events that
occurred after the initial recognition of the asset, and had an impact on the
estimated future cash flows from that asset that can be estimated reliably.

 

Objective evidence that financial assets are impaired includes default or
delinquency by a debtor, restructuring of an amount due to the Group on terms
that the Group would not consider otherwise, indications that a debtor or
issuer will enter bankruptcy, adverse changes in the payment status of
borrowers or issuers, economic conditions that correlate with defaults or the
disappearance of an active market for a security.  In addition, for an
investment in an equity security, a significant or prolonged decline in its
fair value below its cost is objective evidence of impairment.

 

Financial assets measured at amortised cost

The Group considers evidence of impairment for financial assets measured at
amortised cost (loans and receivables) at both a specific asset and collective
level.  All individually significant assets are assessed for specific
impairment.  Those found not to be specifically impaired are then
collectively assessed for any impairment that has been incurred but not yet
identified.  Assets that are not individually significant are collectively
assessed for impairment by grouping together assets with similar risk
characteristics.

 

In assessing collective impairment, the Group uses historical trends of the
probability of default, the timing of recoveries and the amount of loss
incurred, adjusted for management's judgement as to whether current economic
and credit conditions are such that the actual losses are likely to be greater
or less than suggested by historical trends.

 

An impairment loss in respect of a financial asset measured at amortised cost
is calculated as the difference between its carrying amount and the present
value of the estimated future cash flows discounted at the asset's original
effective interest rate.  Losses are recognised in profit or loss and
reflected in an allowance against loans and receivables.  Interest on the
impaired asset continues to be recognised.  When an event occurring after the
impairment was recognised causes the amount of impairment loss to decrease,
the decrease in impairment loss is reversed through profit or loss.

 

Financial assets at fair value through other comprehensive income

Impairment losses on financial assets at FVOCI are recognised by reclassifying
the losses accumulated in the fair value reserve to profit or loss.  The
amount reclassified is the difference between the acquisition cost (net of any
principal repayment and amortisation) and the current fair value, less any
impairment previously recognised in profit or loss.     Impairment losses
recognised in profit or loss for an investment in an equity instrument
classified as FVOCI are not reversed through profit or loss.

 

(ii)           Non-financial assets

The carrying amounts of the Group's non-financial assets are reviewed at each
reporting date to determine whether there is any indication of impairment.
If any such indication exists, the asset's recoverable amount is estimated.
 Indefinite-lived intangible assets are tested annually for impairment or
when there is an indication of impairment.  An impairment loss is recognised
if the carrying amount of an asset or Cash Generating Unit ('CGU') exceeds its
recoverable amount.

 

The recoverable amount of an asset of CGU is the greater of its value in use
and its fair value less costs to sell.  In assessing value in use, the
estimated future cash flows are discounted to their present value using a
pre-tax discount rate that reflects current market assessments of the time
value of money and the risks specific to the asset or CGU.  For the purpose
of impairment testing, assets are grouped together into the smallest group of
assets that generates cash inflows from continuing use that are largely
independent of the cash inflows of other assets or CGUs.  Subject to an
operating segment ceiling test, CGUs to which goodwill has been allocated are
aggregated so that the level at which impairment testing is performed reflects
the lowest level at which goodwill is monitored for internal reporting
purposes.  Goodwill acquired in a business combination is allocated to groups
of CGUs that are expected to benefit from the synergies of the combination.

 

Impairment losses are recognised in profit or loss.  Impairment losses
recognised in respect of CGUs are allocated first to reduce the carrying
amount of any goodwill allocated to the CGU (group of CGUs), and then to
reduce the carrying amounts of the other assets in the CGU (group of CGUs) on
a pro rata basis.

 

An impairment loss is reversed only to the extent that the asset's carrying
amount does not exceed the carrying amount that would have been determined,
net of depreciation or amortisation, if no impairment loss had been
recognised.

 

(g)          Employee benefits

 

        Share-based payments

The grant-date fair value of share-based payment awards granted to employees
is recognised as an employee expense, with a corresponding increase in equity,
over the period that the employees become unconditionally entitled to the
awards.  The amount recognised as an expense is adjusted to reflect the
number of awards for which the related service and non-market performance
conditions are expected to be met, such that the amount ultimately recognised
as an expense is based on the number of awards that meet the related service
and non-market performance conditions at the vesting date.  For share-based
payment awards with non-vesting conditions, the grant-date fair value of the
share-based payment is measured to reflect such conditions and there is no
adjustment for differences between expected and actual outcomes.

 

(i)           Revenue

Revenue from the sale of processed products is recognised when ownership of
the product passes to the purchaser in accordance with the relevant sales
contract. Ownership passes either upon delivery or once the product is
collected where customers arrange delivery.

 

(j)           Finance income and finance costs

Finance income comprises interest income on bank funds.  Interest income is
recognised as it accrues in profit or loss, using the effective interest
method.

Finance costs comprise interest expense on borrowings. Borrowing costs are
recognised in profit or loss in the period in which they are incurred.

 

(k)          Taxation

Tax expense comprises current and deferred tax.  Current and deferred tax is
recognised in profit or loss except to the extent that it relates to a
business combination, or items recognised directly in equity or in other
comprehensive income.

 

Current tax is the expected tax payable or receivable on the taxable income or
loss for the year, using tax rates enacted or substantially enacted at the
reporting date, and any adjustment to tax payable in respect of previous
years.  Current tax payable also includes any tax liability arising from the
declaration of dividends.

 

Deferred tax is recognised in respect of temporary differences between the
carrying amounts of assets and liabilities for financial reporting purposes
and the amounts used for taxation purposes.  Deferred tax is not recognised
for:

 

·          temporary differences on the initial recognition of
assets or liabilities in a transaction that is not a business combination and
that affects neither accounting nor taxable profit or loss;

·          temporary differences related to investments in
subsidiaries and jointly controlled entities to the extent that it is probable
that they will not reverse in the foreseeable future; and

·          taxable temporary differences arising on the initial
recognition of goodwill.

 

Deferred tax is measured at the tax rates that are expected to be applied to
temporary differences when they reverse, using tax rates enacted or
substantively enacted at the reporting date.

 

Deferred tax assets and liabilities are offset if there is a legally
enforceable right to offset current tax liabilities and assets, and they
relate to taxes levied by the same tax authority on the same taxable entity,
or on different tax entities, but they intend to settle current tax
liabilities and assets on a net basis or their tax assets and liabilities will
be realised simultaneously.

 

Deferred tax assets are recognised for unused tax losses, unused tax credits
and deductible temporary differences to the extent that it is probable that
future taxable profits will be available against which they can be used.
Deferred tax assets are reviewed at each reporting date and are reduced to the
extent that it is no longer probable that the related tax benefit will be
realised; such reductions are reversed when the probability of future taxable
profits improves.

 

(l)           Leases

The Group leases certain property, plant and equipment. Leases of plant and
equipment where the Group has substantially all the risks and rewards of
ownership are classified as finance leases under IFRS 16.  Finance leases are
capitalised on the lease's commencement at the lower of the fair value of the
leased assets and the present value of the minimum lease payments. Other
leases are either small in value or cover a period of less than 12 months.

The lease liability is initially measured at the present value of the lease
payments that are not paid. Lease payments generally include fixed payments
less any lease incentives receivable. The lease liability is discounted using
the interest rate implicit in the lease or, if that rate cannot be readily
determined, the Group's incremental borrowing rate. The Group estimates the
incremental borrowing rate based on the lease term, collateral assumptions,
and the economic environment in which the lease is denominated. The lease
liability is subsequently measured at amortized cost using the effective
interest method. The lease liability is remeasured when the expected lease
payments change as a result of new assessments of contractual options and
residual value guarantees.

 

The right-of-use asset is recognised at the present value of the liability at
the commencement date of the lease less any incentives received from the
lessor. Added to the right-of-use asset are initial direct costs, payments
made before the commencement date, and estimated restoration costs. The
right-of-use asset is subsequently depreciated on a straight-line basis from
the commencement date to the earlier of the end of the useful life of the
right-of-use asset or the end of the lease term. The right-of-use asset is
periodically reduced by impairment losses, if any, and adjusted for certain
remeasurements of the lease liability.

 

Each lease payment is allocated between the liability and finance charges. The
corresponding rental obligations, net of finance charges, are included in
lease liabilities, split between current and non-current depending on when the
liabilities are due. The interest element of the finance cost is charged to
the Statement of Profit and Loss over the lease period so as to produce a
constant periodic rate of interest on the remaining balance of the liability
for each period. Assets obtained under finance leases are depreciated over
their useful lives. The lease liabilities are shown in Note 6

 

 

(m)         Inventories

Inventories for processed material and ore stockpiles are valued at the lower
of cost and net realisable value.  Costs allocated to processed material are
based on average costs and include all costs of purchase, conversion and other
costs in bringing these inventories to their existing location and
condition.  Costs allocated to ore stockpiles are based on average costs,
which include an appropriate share of direct mining costs, direct labour and
material costs, mine site overhead, depreciation and amortisation.  If
carrying value exceeds net realisable amount, a write down is recognised.
The write down may be reversed in a subsequent period if the circumstances
which caused it no longer exist.

 

 

(n)          Segment reporting

Segment results that are reported to management include items directly
attributable to a segment as well as those that can be allocated on a
reasonable basis.

 

(o)          Equity reserves

Share premium includes any premiums received on issue of share capital. Any
transaction costs associated with the issue of shares are deducted from share
premium.

The share option/warrant reserve is used to recognise the fair value of
equity-settled share based payment transactions.

The exchange reserve is used to record exchange differences arising from the
translation of foreign subsidiaries into the presentation currency.

The financial assets at FVOCI reserve is used to record unrealised accumulated
changes in fair value on financial assets.

 

5.            New standards and interpretations

There are no amendments to International Financial Reporting Standards (IFRS)
and International Accounting Standards (IAS) that have been implemented by the
Group in the period ended 31 December 2021 and have changed the Group's
accounting policies.

 

Standards, Amendments to published Standards and Interpretations issued but
not yet effective

 

Other new and amended standards and Interpretations issued by the IASB that
will apply for the first time in the next annual financial statements are not
expected to impact the Group as they are either not relevant to the Group's
activities or require accounting which is consistent with the Group's current
accounting policies.

 

6.            Determination of fair values

A number of the Group's accounting policies and disclosures require the
determination of fair value, for both financial and non-financial assets and
liabilities.  Fair values have been determined for measurement and/or
disclosure purposes based on the following methods.  When applicable further
information about the assumptions made in determining fair values is disclosed
in the notes specific to that asset or liability.

 

(i)                   Property, plant and equipment

The fair value of property, plant and equipment recognised as a result of a
business combination is the estimated amount for which a property could be
exchanged on the date of acquisition between a willing buyer and a willing
seller in an arm's length transaction after proper marketing wherein the
parties had each acted knowledgeably.  The fair value of items of plant and
equipment is based on the market approach and cost approaches using quoted
market prices for similar items when available and depreciated replacement
cost when appropriate.  Depreciated replacement cost reflects adjustments for
physical deterioration as well as functional and economic obsolescence.

 

 

 

(ii)                  Intangible assets

The fair value of other intangible assets is based on the discounted cash
flows expected to be derived from the use and eventual sale of the assets.

 

(iii)                Trade and other receivables

The fair value of trade and other receivables is estimated at the present
value of future cash flows, discounted at the market rate of interest at the
reporting date.  This fair value is determined for disclosure purposes or
when such assets are acquired in a business combination.

 

(iv)                 Share-based payments

The fair value of the employee share options is measured using the
Black-Scholes formula.  Measurement inputs include the share price on the
measurement date, the exercise price of the instrument, expected volatility
(based on an evaluation of the Company's historic volatility, particularly
over the historic period commensurate with the expected term), expected term
of the instruments (based on historical experience and general option holder
behaviour), expected dividends, and the risk-free interest rate (based on
government bonds).  Service and non-market

performance conditions attached to the transactions are not taken into account
in determining fair value.

 

(v)                  Investments - other

When one is available, the Group measures the fair value of an instrument
using the quoted price in an active market for that instrument.  A market is
regarded as active if transactions for the asset or liability take place with
sufficient frequency and volume to provide pricing information on an ongoing
basis. A discount is applied to the value of any Performance shares to reflect
the possibility that the milestones for conversion into ordinary shares may
not be met.

 

7.            Operating segments

The Group considers that it operated during the period in two distinct
business areas, being that of manganese production and exploration in West
Africa and phosphate mining in Utah, USA.  These business areas form the
basis of the Group's operating segments.  For each segment, the Group's
Managing Director (the chief operating decision maker) reviews internal
management reports on at least a quarterly basis.

 

Other operations relate to the Group's administrative functions conducted at
its head office and by its intermediate holding company together with
consolidation adjustments.

 

Information regarding the results of each reportable segment is included
below.  Performance is measured based on segment result before tax, as
included in the internal management reports that are reviewed by the Group's
Managing Director.  Segment results are used to measure performance as
management believes that such information is the most relevant in evaluating
the performance of certain segments relative to other entities that operate
within the exploration industry.

 

Information about reportable segments

 

 

15 months ended 31 December 2021

                                                                                                              Other operations

                                                                           Manganese       Phosphate          £'000                       Total

                                                                           £'000           £'000                                          £'000

 External  revenue                                                                 -       451                           -                      451
 Cost of sales                                                             -               495                                            495
 Interest expense                                                          -               -                  -                           -
 Depreciation, amortisation and impairment                                 43              143                1                           187
 Share of associate                                                        -               116                -                           116

 loss to date of becoming subsidiary
 (Loss)/profit before                                                      (60)            (569)              (1,385)                     (2,014)

  tax
 Assets                                                                    1,535           4,229              144                         5,908
 Exploration and capital expenditure                                       1,332           3,274              -                           4,606
 Liabilities                                                               360             2,113              155                         2,628

 

 

Year ended 30 September 2020

                                                                                                   Other operations

                                                                   Manganese       Phosphate       £'000                 Total

                                                                   £'000           £'000                                 £'000

 External revenue                                                  -               -               -                     -
 Interest expense                                                  -               -               -                     -
 Depreciation, amortisation and impairment                         76              -               -                     76
 Share of associate loss                                           -               (4)                                   (4)
 (Loss)/profit before tax                                          (405)           (4)             (833)                 (1,242)
 Assets                                                            1,011           1,622           842                   3,475
 Exploration and capital expenditure                               1               -               -                     1
 Liabilities                                                       285             -               182                   467

 

Information about geographical segments

 

15 months ended 31 December 2021

                                                                 West Africa     US         Other      Total

                                                                 £'000           £'000      £'000      £'000

 External  revenue                                               -               451        -          451
 Cost of sales                                                   -               496        -          496
 Interest expense                                                -               -          -          -
 Depreciation, amortisation and impairment                       43              143        1          187
 Share of associate loss to date of becoming subsidiary          -               (116)      -          (116)
 (Loss)/profit before                                            (44)            (569)      (1,385)    (2,014)

 tax
 Assets                                                          1,541           4,229      138        5,908
 Exploration and capital expenditure                             1,332           3,274      -          4,606
 Liabilities                                                     360             2,113      155        2,628

 

Year ended 30 September 2020

                                                    West

                                                    Africa     US         Other      Total

                                                    £'000      £'000      £'000      £'000

 External revenue                                   -          -          -          -
 Interest expense                                   -          -          -          -
 Depreciation, amortisation and impairment          76         -          -          76
 Share of associate loss                            -          (4)        -          (4)
 (Loss)/profit before tax                           (405)      (4)        (833)      (1,242)
 Assets                                             1,011      1,622      842        3,475
 Exploration and capital expenditure                1          -          -          1
 Liabilities                                        285        -          182        467

 

 

 

8.            Expenses

                                                                 15 months ended 31 December 2021      Year ended 30 September 2020

 Expenses include:                                               £'000                                  £'000

 Depreciation and amortisation expense                                              44                                  76
 Auditor's remuneration
 - Audit fee                                                                        33                                  23
 Foreign exchange differences                                                       12                                  4

 

Auditor's remuneration for the period in respect of the Company amounted to
£11,000 (year ended 30 September 2020: £10,000).

 

9.            Personnel expenses

                                                             15 months ended 31 December 2021      Year ended 30

                                                             £'000                                 September 2020

                                                                                                   £'000
 Wages and salaries                                                             672                          446
 Fees                                                                           100                          158
 Equity-settled share-based payments (see note 23)                              37                           183
                                                                                809                          787

 

Fees in respect of the services of D Reeves are payable to a third party,
Wilgus Investments (Pty) Limited.

 

Fees in respect of the services of R Lamming are payable to a third party,
Parallel Resources Limited for part of the previous period.

 

 

The average number of employees (including directors) during the period was:

                                     15 months ended 31 December 2021      Year ended 30

                                                                           September 2020
 Directors                                              4                            3
 Key management personnel                               -                            1

 Other                                                  3                            3
                                                        7                            7

 

10.          Directors' emoluments

 

15 months ended 31 December 2021

                                    Executive       Non-executive

                                    directors       directors         Total

                                                    £'000

                                    £'000                              £'000

 Wages and salaries (incl. fees)            234     82                316
                                            234              82              316

 

 

 

Year ended 30 September 2020

                                                          Executive       Non-executive directors

                                                          directors       £'000                       Total

                                                          £'000                                        £'000

 Wages and salaries (incl. fees)                                  152     66                          218
 Compensation payment resulting from SARS cancellation

                                                                  120     -                           120
                                                                  272                   66                   338

 

These amounts are disclosed by director in the Directors' report on page 15.

 

Emoluments disclosed above include the following amounts payable to the
highest paid director:

 

                                                15 months ended 31 December 2021      Year ended 30

                                                £'000                                 September 2020

                                                                                      £'000
 Emoluments for qualifying services                                219                          272

 

 

Key management personnel

Included in note 10 are emoluments paid to key management personnel in the
period which amounted to £70,000 (year ended 30 September 2020: £71,000).

 

11.          Finance costs

 

Recognised in loss for period

                15 months ended  Year ended 30 September 2020

                31 December      £'000

                2021

                £'000

 

 

 Other        43    3
              43    3

12.          Taxation

 

Current tax

                                                                        15 months ended 31 December 2021      Year ended 30 September 2020

                                                                        £'000                                 £'000
 Tax recognised in profit or loss
 Current tax
 Current period                                                         -                                     -

 Deferred tax
 Origination and reversal of temporary differences                      -                                     -

 Total tax                                                              -                                     -

 

 

Reconciliation of effective tax rate

                                                                                   15 months ended 31 December 2021      Year ended 30 September 2020

                                                                                   £'000                                 £'000

 Loss before tax (continuing operations)                                           (2,014)                               (1,242)

 Tax using the Company's domestic tax rate of 19.0% (2020: 19.0%)                  (383)                                 (236)

 Effects of:
 Expenses not deductible for tax purposes                                          2                                     3
 Overseas (profits)/losses                                                         116                                   93
 Equity-settled share-based payments                                               7                                     12
 Tax losses carried forward not recognised as a deferred tax asset                 258                                   128
                                                                                   -                                     -

 

None of the components of other comprehensive income have a tax impact.

 

Factors that may affect future tax charges

At the period end, the Group had unused tax losses available for offset
against suitable future profits of approximately £7,128,000 (year ended 30
September 2020: £5,771,000). A deferred tax asset has not been recognised in
respect of such losses due to uncertainty of future profit streams.

 

 

13.          Property, plant and equipment

 

Group

                                                         Plant and equipment     Office and computer equipment     Motor vehicles

                                                                                 £'000                                                     Total

                                                         £'000                                                     £'000

                                                                                                                                           £'000
 Cost
 Balance at 1 October 2019                                           360                          31                         19            410
 Additions                                                           -                            -                          -             -
 Disposals                                                           (39)                         (6)                        (19)          (64)
 Effect of movements in exchange rates                               8                            -                          -             8
 Balance at 30 September 2020                                        329                          25                         -             354

 Balance at 1 October 2020                                           329                          25                         -             354
 Acquisition of Falcon Isle                                          172                                                                   172
 Additions                                                           185                          3                          -             188
 Disposals                                                           -                            -                          -             -
 Effect of movements in exchange rates                               (25)                         -                          -             (25)
 Balance at 31 December 2021                                         661                          28                         -             689

 Depreciation and impairment provisions
 Balance at 1 October 2019                                           29                           30                         19            78
 Depreciation for the year                                           76                           -                          -             76
 Depreciation on disposals                                           (39)                         (6)                        (19)          (64)
 Effect of movements in exchange rates                               1                            -                          -             1
 Balance at 30 September 2020                                        67                           24                         -             91

 Balance at 1 October 2020                                           67                           24                         -             91
 Depreciation for the period                                         34                           2                          -             36
 Depreciation on disposals                                           -                            -                          -             -
 Effect of movements in exchange rates                               8                            -                          -             8
 Balance at 31 December 2021                                         109                          26                         -             135

 Carrying amounts
 At 30 September 2019                                                331                          1                          -             332
 At 30 September 2020                                                262                          1                          -             263
 At 31 December 2021                                                 552                          2                          -             554

 

Company

                                                                         Plant and       Computer equipment

                                                                         equipment       £'000                       Total

                                                                         £'000                                       £'000
 Cost
 Balance at 1 October 2019                                                       -                   5               5
 Transfers                                                                       -                   -               -
 Balance at 30 September 2020                                                    -                   5               5

 Balance at 1 October 2020                                                       -                   5               5
 Additions                                                                       -                   3               3
 Balance at 31 December 2021                                                     -                   8               8

 Depreciation and impairment provisions
 Balance at 1 October 2019                                                       -                   5               5
 Depreciation for the year                                                       -                   -               -
 Balance at 30 September 2020                                                    -                   5               5

 Balance at 1 October 2020                                                       -                   5               5
 Depreciation for the period                                                     -                   1               1
 Balance at 31 December 2021                                                     -                   6               6

 Carrying amounts
 At 30 September 2019                                                            -                   -               -
 At 30 September 2020                                                            -                   -               -
 At 31 December 2021                                                             -                   2               2

 

 

 

14.          Intangible assets - Group

                                                                                    Prospecting and exploration rights

                                                                                    £'000

 Cost
 Balance at 1 October 2019                                                          1,206
 Additions                                                                          1
 Disposals                                                                          -
 Effect of movement in exchange rates                                               20
 Balance at 30 September 2020                                                       1,227

 

 Balance at 1 October 2020                            1,227
 Acquisition of Falcon Isle (note 15)                 3,046
 Additions                                            538
 Disposals                                            (158)
 Effect of movements in exchange rates                (10)
 Balance at 31 December 2021                          4,643

 

 Amortisation and impairment losses
 Balance at 1 October 2019                                                     155
 Impairment                                                                    -
 Amortisation                                                                  -
 Disposals                                                                     -

 Effect of movements in exchange rates                                         3
 Balance at 30 September 2020                                                  158

 

 Balance at 1 October 2020                            158
 Impairment                                           -
 Amortisation                                         37
 Disposals                                            (158)
 Effect of movements in exchange rates                -
 Balance at 31 December 2021                          37

 

 Carrying amounts
 Balance at 30 September 2019                                 1,051
 Balance at 30 September 2020                                 1,069
 Balance at 31 December 2021                                  4,606

 

The carrying value of the prospecting and exploration rights is supported by
the estimated resource and current market values.

 

 

15.          Investments in subsidiaries and associates

 

 Company - subsidiaries

                                                                         2021                2020

                                                                         £'000               £'000
 Equity investments
 Balance at beginning of period                                                    -               -
 Additions - from associates                                                       1,959           -
 Disposals                                                                         -               -
 Balance at 31 December/30 September                                               1,959           -

 

                                                                                   Country of      Ownership interest
                                                                Activity  incorporation            2021              2020
 Directly
 Southern Iron Limited            Investment                                       Guernsey        100%              100%
 Falcon Isle Resources LLC        Mining                                           USA             51%               40%

 Indirectly
 Société Générale des Mines SA                      Exploration                    Togo            85%               85%

Registered offices of subsidiary companies are:

Southern Iron Limited, 1st Floor, Elizabeth House, Les Ruettes Brayes, St
Peter Port, Guernsey

Société Générale des Mines, Quartier Adidogome Apedokoe 02, BP 20022,
Lome, Togo

Falcon Isle Resources LLC, 8 The Green, Suite B8, Dover, Kent, Delaware 19901,
USA

 

Group and Company - associates

                                                   2021         2020

                                                   £'000        £'000
 Accounted for using the equity method

 At 1 October                                      1,622        -
 Additions - including acquisition costs           453          1,626
 Share of loss for the period                      (116)        (4)
 Transfer to investment in subsidiary              (1,959)      -
 At 31 December/30 September                       -            1,622

 

 

The interest in Falcon Isle was acquired for nominal consideration under a
binding heads of terms dated 28 July 2020. Under this agreement the Company
agreed to provide US$2.5m in loans to Falcon Isle payable in agreed
tranches.  Falcon Isle is the 100% owner of the Diamond Creek phosphate
mine located in in Utah (USA) which is a fully permitted, high grade direct
shipping ore organic phosphate operating mine.

 

At 30 September 2020 the Company had advanced US$ 1.9m to Falcon Isle,
resulting in an equity interest of 40% and bringing the cost of the investment
in the associate to £1,626,000.

 

On 31 December 2020 the Company advanced the balance of $0.6m and its equity
interest has increased to a controlling interest of 51%.

 

The initial acquisitions were accounted for under the equity method of
accounting but upon achieving control on 31 December 2020, the acquisition
method of accounting has been applied.

 

Since 31 December 2021, on 29 March 2022, the Company agreed to acquire the
outstanding 49% equity interest in Falcon Isle and loans totalling $1,816,527
made by the vendor to Falcon Isle, for total consideration of $3.2 million,
payable in four annual tranches commencing on 1 July 2022.

 

From the date of the acquisition on 31 December 2020 to 31 December 2021,
Falcon Isle Resources recognized revenue of £452,000 and incurred a loss of
£569,000. If the acquisition had occurred on 1 October 2020 the Group's
revenue and loss for the 15-month period ended 31 December 2021 would have
been £548,000 and £2,261,000 respectively.

 

The fair value of assets and liabilities acquired on acquisitions are as
follows:

                                               Fair value

                                               £'000

 Intangibles                                   3,046
 Fixed assets                                  172
 Inventory                                     57
 Receivables                                   122
 Bank balances and cash                        158
 Trade and other payables                      (17)
 Loans                                         (1,330)
                                               2,208

 

The investment in associate was revalued prior to acquisition to fair value
based on the price paid to acquire the additional 11% shareholding. Under IFRS
3, on acquisition of the controlling stake, the Group remeasured its original
40% investment in Falcon Isle. This led to a loss on change of ownership of
£363,000 being recognised in the Consolidated Statement of Comprehensive
Income.

 

On acquisition the non-controlling interest, valued based upon net assets at
acquisition, was valued at £645,000. No goodwill has arisen from the
acquisition.

 

16.          Leases

 

The following lease liabilities arose in respect of the recognition of right
of use assets with a net book value of £219,000. The Group holds one lease
that it accounts for under IFRS 16.

 

The right of use assets are as follows:

                                                         £000
 Balance at 30 September 2020                            -
 Additions                                               314
 Depreciation                                            (99)
 Balance at 31 December 2021                             215

 The lease liability is as follows:
                                                         £000
 Balance at 30 September 2020                            -
 Addition                                                314
 Principal reduction                                     (105)
 Finance cost                                            10
 Balance at 31 December 2021                             219
 Less: Current portion                                   (107)
 Non-current portion                                     112

 

A maturity analysis of the undiscounted minimum lease payments due are as
follows:

                                                   £000
 Lease liabilities - minimum lease payments
 No later than one year                            116
 Later than one year and no later than five years  116
 Later than five years                             -
 Total                                             232

 

17.          Loans

 

Company - current

                                               2021         2020

                                               £'000        £'000
 Balance at beginning of period                1,534        1,379
 Funds advanced to subsidiaries                547          159
 Repaid/impaired                               -            (4)
 Balance at 31 December/30 September           2,081        1,534

 

All loans to subsidiaries are currently unsecured and interest free and
repayable on demand. All loans are denominated in GBP.

 

18.          Inventories

 

                                                                                2021         2020

                                                                                £'000        £'000
 Phosphate, including processed material held for sale                          273          -
                                                                                273          -

 

 

19.       Trade and other receivables

 

Group

                               2021         2020

                               £'000        £'000
 Trade receivables             7            -
 Other receivables             87           71
 Prepayments                   -            12
                               94           83

Company

                               2021         2020

                               £'000        £'000
 Other receivables             20           58
 Prepayments                   -            12
                               20           70

 

Other receivables are stated at their nominal value less allowances for
non-recoverability.

The Group and Company's exposure to credit and currency risk is disclosed in
note 24 and 25. Trade receivables are net of a provision for bad debts of
£nil (2020: £nil)

 

20.          Cash and cash equivalents

 

Group

                                       2021         2020

                                       £'000        £'000
 Bank balances                         166          438
 Cash and cash equivalents             166          438

 

Company

                                       2021         2020

                                       £'000        £'000
 Bank balances                         122          428
 Cash and cash equivalents             122          428

 

There is no material difference between the fair value of cash and cash
equivalents and their book value.

 

21.        Capital and reserves

 

Share capital

                                                                                                   Number of old ordinary shares £0.001 each

                                                                                                   31 December 2021            30 September 2020
 In issue at beginning of year                                                                     -                           2,491,358,439
 Issued for cash                                                                                   -                           7,000,000
 Issued in settlement of debt                                                                      -                           -
 Cancelled under capital reduction                                                                 -                           (2,498,358,439)
 In issue at 31 December/30 September - fully paid                                                 -                           -

                                                                                                   Number of new ordinary shares £0.0001 each

 In issue at beginning of period                                                                   31 December 2021            30 September 2020

 Resulting from capital reduction                                                                  4,866,007,851
 Issued for cash

                                                                                                   -                           -

                                                                                                   1,369,565,217               2,498,358,439

                                                                                                                               1,646,678,326
 Issued in settlement of debt                                                                      60,500,000                  720,971,086
 In issue at 31 December/30 September  - fully paid                                                6,296,073,068                                              4,866,007,851

                                                                                                   Number of deferred shares

                                                                                                   of £0.004 each
                                                                                                   31 December 2021                                           30 September 2020
 In issue at beginning of year                                                                     -                                                          1,193,794,390
 Cancelled under capital reduction                                                                 -                                                          (1,193,794,390)
 In issue at 31 December/30 September - fully paid                                                 -                                                          -

                                                                                                   Ordinary and deferred share capital

                                                                                                   31 December 2021                                30 September 2020

                                                                                                   £'000                                           £'000
 Balance at beginning of year                                                                      487                                             7,266
 Share issues                                                                                      143                                             244
 Deferred shares cancelled                                                                         -                                               (4,775)
 Capital reduction                                                                                 -                                               (2,248)
 Balance at 31 December/30 September                                                               630                                   487

 

31 December 2021

4,866,007,851

-

1,369,565,217

 

30 September 2020

 

-

2,498,358,439

1,646,678,326

Issued in settlement of debt

 

60,500,000

720,971,086

In issue at 31 December/30 September  - fully paid

 

6,296,073,068

4,866,007,851

 

 

 

 

 

 

Number of deferred shares

of £0.004 each

 

31 December 2021

 

30 September 2020

In issue at beginning of year

 

-

1,193,794,390

Cancelled under capital reduction

 

-

(1,193,794,390)

In issue at 31 December/30 September - fully paid

 

-

-

 

 

 

 

 

 

 

Ordinary and deferred share capital

 

 

 

31 December 2021

£'000

 

30 September 2020

£'000

Balance at beginning of year

 

 

487

7,266

Share issues

 

 

143

244

Deferred shares cancelled

 

 

-

(4,775)

Capital reduction

 

 

-

(2,248)

Balance at 31 December/30 September

630

487

 

 

All ordinary shares rank equally with regard to the Company's residual assets.
The holders of ordinary shares are entitled to receive dividends as declared
from time to time, and are entitled to one vote per share at general meetings
of the Company.

 

Issues of ordinary shares

On 18 December 2020, 400,000,000 ordinary shares were issued for cash at
£0.0011 per share.

On 18 December 2020 B Moritz and D Reeves, conditionally agreed to subscribe
for 36,363,636 and 63,636,364 shares each at £0.0011 per share, these were
issued on 18 January 2021 following a General Meeting to grant increased
authority to issue shares.

On 18 January 2021, 869,565,217 ordinary shares were agreed to be issued at
£0.00115 per share, of these, B Moritz conditionally agreed to subscribe for
17,391,304 shares and R Lamming conditionally agreed to subscribe for
26,086,957 shares in lieu of part of his salary. Of these shares, 600,000,000
were issued on 18 January 2021 and the balance of 269,565,217 were issued on
15 February 2021 following a General Meeting to grant increased authority to
issue shares.

On 18 January 2021, the company conditionally agreed to issue 48,000,000
ordinary shares at £0.00115 per share in settlement of amounts owing to
advisors.  These were issued on 15 February 2021 following a General Meeting
to grant increased authority to issue shares.

On 8 November 2021 G Stacey agreed to convert £7,500 of his outstanding fees
into 12,500,000 new ordinary shares of 0.01pence each at a price of 0.06p per
share.

 

 Warrants
                                                  31 December 2021                        30 September 2020

                                                  Average exercise price  Number         Average exercise price  Number

        In issue at beginning of period           0.24p                   984,357,334    0.36p                    7,000,000
        Lapsed                                    0.24p                   (984,357,334)  -                       -
        Issued in period                          0.22p                   250,000,000    0.24p                   984,357,334
        Lapsed                                    0.22p                   (250,000,000)  -                       -
        Issued in period                          0.18p                   434,785,608    -                       -
        Exercised in period                       -                       -              0.36p                   (7,000,000)
        In issue at 31 December/30 September      0.18p                   434,785,608    0.24p                   984,357,334

 

On 18 December 2020 250,000,000 warrants were agreed to be  issued to
subscribers for the New Ordinary Shares agreed to be issued for cash on 18
December 2020 on the basis of 1 warrant for every 2 shares subscribed.  The
warrants are exercisable at price of 0.22p at any time up to 31 December 2021.

On 18 January 2021 434,785,608 warrants were agreed to be  issued to
subscribers for the New Ordinary Shares agreed to be issued for cash on 18
January 2021 on the basis of 1 warrant for every 2 shares subscribed.  The
warrants are exercisable at price of 0.18p at any time up to 28 February 2022.

            The weighted average remaining contractual life of the
warrants outstanding is 59 days.

Other reserves

Share option/warrant reserve

The share option/warrant reserve comprises the cumulative entries made to the
consolidated statement of comprehensive income in respect of equity-settled
share-based payments as adjusted for share options cancelled.

 

Exchange reserve

The exchange reserve comprises all foreign currency differences arising from
the translation of the financial statements of foreign operations.

 

Fair value reserve

The fair value reserve comprised the cumulative net change in the fair value
of available-for-sale financial assets until the assets were derecognised or
impaired.

 

22.          Earnings per share

 

Basic and diluted earnings/(loss) per share

The calculation of basic earnings/(loss) per share at 31 December 2021 is
based on the following (loss)/profit attributable to ordinary shareholders and
a weighted average number of ordinary shares in issue.

 

Loss attributable to ordinary shareholders (£)

                                                                 15 months ended 31 December 2021

                                                                                                       Year ended 30 September 2020
 Continuing operations                                           (1,948,000)                           (1,181,000)
 Loss attributable to ordinary shareholders                      (1,948,000)                           (1,181,000)

 

Weighted average number of ordinary shares

                                                                                       15 months ended 31 December 2021

                                                                                                                             Year ended 30 September 2020
 Issued ordinary shares at beginning of year                                           4,866,007,851                         2,491,358,439
 Effect of shares issued                                                               1,085,483,160                         444,668,141
 Weighted average number of ordinary shares                                            5,951,491,011                         2,936,026,580

 

The warrants in issue are considered to be antidilutive and as a result, basic
and diluted loss per share are the same.

 

23.         Share-based payments

 

The Company established an Enterprise Management Incentive Scheme to
incentivise Directors and senior executives.  On 17 January 2020, 120,000,000
options were granted at £0.001639 with 10,000,000 vesting immediately,
30,000,000 vesting on 9 March 2020, 30,000,000 vesting on 17 January 2021,

30,000,000 vesting on 17 January 2022 and 20,000,000 vesting on 17 January
2023. The options lapse if not exercised within 5 years. Of the total,
90,000,000 options were granted to R Lamming, a Director.

 

The Black Scholes pricing model was used to calculate the share based payment
charge incorporating an annual volatility rate of 55%, expected life of
between 2 and 5 years and risk free investment rate of between 0.23% and
0.39%. The charge for the year ended 30 September 2020 for these rights which
was included in administrative and exploration expenses amounted to
£63,000.

 

On 7 April 2021, 10,000,000 options were granted at £0.001183 with 3,333,333
vesting on 1 April 2022, 3,333,333 vesting on 1 April 2023 and 3,333,334
vesting on 1 April 2024.  The options lapse if not exercised within 5 years.

 

The Black Scholes pricing model was used to calculate the share based payment
charge incorporating an annual volatility rate of 57%, expected life of
between 4 and 6 years and risk free investment rate of between 0.6% and 0.93%.
The charge for the period ended 31 December 2021 for these rights which was
included in administrative and exploration expenses amounted to £5,000.

 

On 27 May 2021, 15,000,000 options were granted at £0.001121 with 5,000,000
vesting on 17 May 2022, 5,000,000 vesting on 17 May 2023 and 5,000,000 vesting
on 17 May 2024.  The options lapse if not exercised within 3 years of the
vesting dates.

 

The Black Scholes pricing model was used to calculate the share based payment
charge incorporating an annual volatility rate of 57%, expected life of
between 4 and 6 years and risk free investment rate of between 0.6% and 0.93%.
The charge for the period ended 31 December 2021 for these rights which was
included in administrative and exploration expenses amounted to £7,000.

 

 

24.          Trade and other payables

 

Group - Current

 

                                                                      2021         2020

                                                                      £'000        £'000
 Trade payables                                                       962          104
 Accrued expenses                                                     93           228
 Amounts due to Falcon Isle Resources' minority interest              593          -
 Other payables                                                       11           135
                                                                      1,658        467

 

 Group - Non-Current                                                  2021         2020

                                                                      £'000        £'000
 Amounts due to Falcon Isle Resources' minority interest              749          -
                                                                      749          -

 

Company - Current

                               2021         2020

                               £'000        £'000
 Trade payables                46           21
 Accrued expenses              91           97
 Other payables                13           64
                               150          182

 

There is no material difference between the fair value of trade and other
payables and accruals and their book value.  The Group's and Company's
exposure to currency and liquidity risk related to trade and other payables is
disclosed in note 25.

 

25.           Financial instruments

 

Financial risk management

The Group's operations expose it to a variety of financial risks that include
liquidity risk.  The Group has in place a risk management programme that
seeks to limit the adverse effect of such risks on its financial performance.

 

 

                Credit risk

Credit risk is the risk of financial loss to the Group if a customer or
counterparty to a financial instrument fails to meet its contractual
obligations.

 

Exposure to credit risk

The carrying amount of financial assets represents the maximum credit
exposure.  The maximum exposure to credit risk at the reporting date was as
follows.

 

Group

                                          Financial assets at amortised cost
                                          Carrying amount

                                          2021                        2020

                                          £'000                       £'000
 Trade and other receivables              94                          67
 Cash and cash equivalents                166                         438
                                          260                         505

 

Company

                                          Financial assets at amortised cost
                                          Carrying amount

                                          2021                        2020

                                          £'000                       £'000
 Loans                                    2,081                       1,534
 Trade and other receivables              20                          56
 Cash and cash equivalents                122                         428
                                          2,223                       2,018

 

Liquidity risk

Liquidity risk is the risk that the Group will encounter difficulty in meeting
the obligations associated with its financial liabilities that are settled by
delivering cash or another financial asset.

 

The Group reviews its facilities regularly to ensure it has adequate funds for
operations and expansion plans.

 

The following are the contractual maturities of financial liabilities,
including estimated interest payments and excluding the impact of netting
agreements.

 

 

Group

2021

                                                    Carrying amount      Contractual cash flows    2 months      2-12 months

                                                    £'000                £'000                     or less       £'000

                                                                                                   £'000
 Non-derivative financial liabilities
 Trade and other payables                           1,658                (1,658)                   (168)         (1,490)
 Lease liabilities                                  107                  (107)                     (19)          (88)
                                                    1,765                (1,765)                   (187)         (1,578)

 

 

Group

2020

                                                    Carrying amount      Contractual cash flows    2 months      2-12 months

                                                    £'000                £'000                     or less       £'000

                                                                                                   £'000
 Non-derivative financial liabilities
 Trade and other payables                           467                  (467)                     (78)          (389)
                                                    467                  (467)                     (78)          (389)

 

 

Company

2021

                                       Carrying amount      Contractual cash flows    2 months or less      2-12 months

                                       £'000                £'000                     £'000                 £'000
 Non-derivative financial liabilities
 Trade and other payables              150                  (150)                     (25)                  (125)
                                       150                  (150)                     (25)                  (125)

 

 

 

Company

2020

                                       Carrying amount      Contractual cash flows    2 months or less      2-12 months

                                       £'000                £'000                     £'000                 £'000
 Non-derivative financial liabilities
 Trade and other payables              182                  (182)                     (30)                  (152)
                                       182                  (182)                     (30)                  (152)

 

Market risk

Market risk is the risk that changes in market prices, such as foreign
exchange rates, interest rates and equity prices will affect the Group's
income or the value of its holdings of financial instruments.  The objective
of market risk management is to manage and control market risk exposures
within acceptable parameters, while optimising the return.

 

Currency risk

The Group is exposed to foreign currency risk on purchases that are
denominated in currencies other than GBP.  The currencies giving rise to this
risk are primarily the CFA Franc and the US dollar.

 

Fair values

The fair values of financial instruments such as trade and other
receivables/payables are substantially equivalent to carrying amounts
reflected in the balance sheet.

 

Capital management

The Group's objective when managing capital is to safeguard its accumulated
capital in order to provide an adequate return to shareholders by maintaining
a sufficient level of funds, in order to support continued operations.

 

The Group considers its capital to be total shareholders' equity which at 31
December 2021 for the Group totalled £3,053,000 (30 September 2020:
£3,148,000) and for the Company totalled £4,034,000 (30 September 2020:
£3,472,000).

 

 

26.          Related parties

 

The Group's related parties include its key management personnel and others as
described below.

 

No guarantees have been given or received and all outstanding balances are
usually settled in cash.

 

Of the remuneration payable to D Reeves, £25,000 remains unpaid as at 31
December 2021(30 September 2020 - £31,000).

 

Other related party transactions

 

Transactions with Group companies

The Company had the following related party balances from financing
activities:

                                                                  2021         2020

                                                                  £'000        £'000
 Southern Iron Limited
 -  Loans and receivables (interest free)                         1,622        1,534

 Falcon Isle Resources LLC
 -  Loans and receivables (interest free)                         459          -

 

 

 

 

459

-

Southern Iron Limited had the following related party balances from financing
activities:

 Société Générale des Mines SA
 -  Loans and receivables (interest free)                   1,777      1,694

27.         Subsequent events

 

Issues of New Ordinary Shares

On 26 April 2022 the Company announced the raising of a total
of £1,950,000 (before expenses) by the issue of up to 1,625,000,000 new
Ordinary Shares at a price of 0.12p per share. 1,000,000,000 new Ordinary
Shares were placed for cash consideration to raise £1,200,000 and the
balance of 625,000,000 new Ordinary Shares were issued through a Broker Option
following approval at a General Meeting of the company held on 16 May 2022.

 

Each new Ordinary Share subscribed received a warrant to subscribe for 1 new
Ordinary Share at any time up to 31 May 2024, at an exercise price of 0.18p
per share.

 

Falcon Isle

On 29 March 2022, the Company agreed to acquire the outstanding 49% equity
interest in Falcon Isle and loans totalling $1,816,527 made by the vendor to
Falcon Isle, for total consideration of $3.2 million, payable in four annual
tranches of $800,000 commencing on 1 July 2022.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FR BKCBDKBKBPAB

Recent news on Keras Resources

See all news